ConditionChronic Kidney Disease 5D
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCharite University, Berlin, Germany
About this trial
An adequate fiber intake is crucial for a well-balanced diet and reduces the risk of chronic diseases. However, nutritional recommendations for chronic kidney disease patients lead to an insufficient fiber intake with possible maladaptive effects on the gut microbiome. Therefore, we want to study the effects of a 35-day inulin supplementation on the gut microbiome, gut barrier function, bacterial metabolites and immune cell states in chronic kidney disease patients.
Eligibility criteria
Qualifiers
Men and women in a ratio of 1:1
Age 18-75 years
Body mass index 25.0 - 39.9 kg/m²
End-stage kidney disease, which has been treated regularly with hemodialysis for at least 3 months
Disqualifiers
Malignant diseases
Recent or current hospitalization
Postoperative phase
Acute infections
Trial design
Treatments tested in this trial
- Inulin
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov